RedETSA Convenes 38 HTA Institutions for Americas Summit
Regional HTA network addresses equity, economic evaluation, and adaptation frameworks.
Read MorePosted by Shajini | Jun 9, 2025 | News, Pricing & Market Access
Regional HTA network addresses equity, economic evaluation, and adaptation frameworks.
Read MorePosted by Shajini | Jun 9, 2025 | News, Pricing & Market Access
Platform achieves 30% market dominance in Medicare Advantage bid submissions.
Read MorePosted by Shajini | Jun 6, 2025 | News, Pricing & Market Access
The National Institute for Health and Care Excellence (NICE) has approved linzagolix combined with hormonal add-back therapy for endometriosis treatment within the NHS, expanding therapeutic options for an estimated 1.5 million...
Read MorePosted by Shajini | Jun 6, 2025 | News, Orthopaedics, Pricing & Market Access
A validated capacity assessment tool designed to strengthen orthopedic surgery capabilities in low- and middle-income countries (LMICs) has demonstrated excellent reliability and practical utility in pilot testing, addressing a...
Read MorePosted by Shajini | Jun 6, 2025 | News, Pricing & Market Access
Medicare has approved coverage for Natera’s genome-based Signatera molecular residual disease (MRD) assay under LCD L38779, extending access to beneficiaries across six cancer indications. The coverage applies to...
Read More